Stock LGSTU SEMR PARA
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Other languages SEMR PARA Nasdaq

Equities

LGSTU

KYG8028L1234

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Semper Paratus Acquisition Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
SEMR PARA : Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments - Form 8-K
Tevogen Bio Holdings Inc., a Cell Therapy Company, Announces Completion of Business Combination and is to be Listed on Nasdaq Under Ticker TVGN
Semper Paratus Acquisition Corporation(NasdaqGM:LGST) dropped from NASDAQ Composite Index
Tevogen Bio Inc completed the acquisition of Semper Paratus Acquisition Corporation from a group of shareholders in a reverse merger transaction.
Semper Paratus Acquisition Shareholders Approve Tevogen Bio Deal
Semper Paratus Acquisition Corporation’s Shareholders Approve Business Combination with Tevogen Bio
Semper Paratus Acquisition Corporation Announces Anticipated Listing of Tevogen Bio Holdings Inc. on Nasdaq
Tevogen Bio Inc. and Semper Paratus Acquisition Corporation Announce Effectiveness of Registration Statement for Business Combination
Semper Paratus Acquisition : Submission of Matters to a Vote of Security Holders - Form 8-K
Semper Paratus Acquisition Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Semper Paratus Acquisition Corporation Regains Compliance with Certain Nasdaq Listing Requirement
Semper Paratus Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Semper Paratus Acquisition to Merge With Tevogen Bio; to Bring Tevogen Public
Biotech firm Tevogen Bio enters $1.2 bln SPAC deal for US listing
Biotech firm Tevogen Bio to go public in $1.2 billion SPAC deal
Tevogen Bio to Become Publicly Listed on NYSE via Business Combination with Semper Paratus Acquisition Corporation
Tevogen Bio Inc entered into a merger agreement to acquire Semper Paratus Acquisition Corporation for $1.5 billion in a reverse merger transaction.
Insider Sell: Semper Paratus Acquisition
SEMPER PARATUS ACQUISITION CORP : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LGST Stock
  4. LGSTU Stock
  5. News SEMR PARA
  6. Other languages